The Predictive Role of PIK3CA Mutation Status on PI3K Inhibitors in HR+ Breast Cancer Therapy: A Systematic Review and Meta-Analysis

AIM: To evaluate the impact of PIK3CA mutation status on clinical outcomes of HR+ breast cancer treated with PI3K inhibitors. METHODS: A comprehensive literature search was conducted in online databases from inception to December 31, 2019. The main characteristics and prognostic data of each eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingming, Li, Jin, Huang, Jiangsheng, Luo, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238354/
https://www.ncbi.nlm.nih.gov/pubmed/32461963
http://dx.doi.org/10.1155/2020/1598037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238354/
https://www.ncbi.nlm.nih.gov/pubmed/32461963
http://dx.doi.org/10.1155/2020/1598037

Ejemplares similares